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ADJUVANTS are considered to play an important role in
directing the isotype and amount of antibodies produced
upon immunization by conducting the development of
either Th-1 or Th-2 cells upon T-cell stimulation. This is
based on the different cytokine production patterns that
were observed after in vitro resttmulation of T cells iso-
lated from mice immunized with antigen either adsorbed
on alum or emulsified in complete Freund adjuvant
(CFA). However, other studies suggest that primarily the
type of antigen determines which isotypes are produced
and to what extent. In these studies, however, IgE was not
determined. Therefore, this study examined whether
alum and CFA influenced the amount and/or ratio ofIgG1,
IgE and IgG,= produced after TNP-KLH immunization.
Similar levels ofIgG1, IgE and IgG2a antibodies were found
upon immunization with TNP-KLH either adsorbed on
alum or emulsified in CFA. Moreover, administration of
IFN- in combination with TNP-KLH adsorbed on alum
did not increase the amount of IgG produced. IFN-T
treatment resulted in an increased IL-6 and decreased
IFN- production by spleen cells upon ConA stimulation,
whereas it did not change the IL-4 production in similar
conditions. The presented results suggest that upon im-
munization with TNP-KLH high IL-4 levels are produced,
resulting in an antibody response that is dominated by
IgG, independent of the adjuvant employed. The IL-4
inducing property of TNP-KLH is substantiated by the
finding that repeated immunization of mice with
TNP-KI, without adjuvant, increases the serum total IgE
level. The presented data suggest that the carrier part of
TNP-KLH preferentially results in Th-2 cell activity after
which the adjuvant merely enhances the antibody re-
sponses generated.
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Introduction
Helper T cells (Th) play an important role in
antigen induced humoral immune responses. At
least two effector subpopulations of murine Th cells,
differentiated according to the spectrum of cytokines
produced, have been reported.2,3 Th-1 cells
exclusively produce IL-2 and IFN-7, whereas Tho2
cells exclusively produce IL-4, IL-5 and IL-10, but
not IL-2 and IFN-. It has been described that
adjuvant, used to facilitate the induction of antigen
specific immune responses, plays an important role
in determining which T cell subset will be activated
in vivo.4,s Immunization of mice with either
ovalbumin (OVA) or ragweed pollen extract in the
presence of alum resulted in T cells that produced IL-
2, IL-4 and IFN-7 upon in vitro restimulation with the
same antigen. In contrast, immunization with either
OVA or ragweed pollen extract in the presence of
complete Freund adjuvant (CFA) resulted in T cells
that produced IL-2 .and IFN-7, but not IL-4 upon in
vitro restimulation. The amount of IFN-7 produced
by T cells from mice primed with antigen emulsified
in CFA and cultured in the absence of antigen was
markedly higher than the production of IFN-7 in
similar cultures of T cells from mice primed with
antigen adsorbed on alum.6
Based on these results is was suggested that alum
augments preferentially Th-2 mediated responses,
whereas CFA augments preferentially Th-1 mediated
responses. Antigen adsorbed on alum would thus be
expected to induce IgG1 and IgE responses, since IL-
4 is involved in the process of isotype switching to
IgGx and IgE.7,8 Upon immunization in the presence
of CFA, the same antigen would be expected to elicit
a preferential IgG2a response, since IFN-7 has been
reported to enhance IgG2a production. Moreover, IL-
4 inhibits IgGaa production, whereas IFN-7 decreases
both the IgG and IgE synthesis,9 indicating that the
balance between these two cytokines determines the
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amount and isotype of antibodies that will be pro-
duced.
The authors have recently shown that primary TNP
specific IgE responses are completely dependent on
IL-4 and can be largely inhibited by IFN-,, whereas
secondary antigen specific IgE responses are partially
IL-4 independent and can hardly be inhibited by IFN-
, in a concentration that inhibits the primary TNP
specific IgE response.1
In the literature contradictory results have been
described concerning the effects on the isotype
production profile and concentration of antibody
depending on the type of adjuvant employed. More-
over, immunization with different antigens (HSA,
FITC, cytochrome C) showed different effects on the
isotype production profile and amount of antibodies
when administered either adsorbed on alum or emul-
sified in CFA. 11-13 However, in these studies the IgE
isotype was not determined. The presence of this
isotype, however, is indicative for the balance be-
tween IL-4 and IFN-, in vivo.
It was reported by Beck et al. that immunization
with OVA in alum resulted in higher levels of antigen
specific IgE than when administered in CFA. TM How-
ever, the observed antigen specific serum IgG1 and
IgG,.a responses were not influenced when using
either alum or CFA as adjuvant. These authors sug-
gested that primarily the type of adjuvant determined
the resulting IgE production. TM From other studies it
can be concluded that the type of antigen plays, next
to the type of adjuvant, a determining role in the
production of other isotypes than IgE.>3
The effect of alum and CFA as adjuvant on the
antigen specific IgG1 and IgG2a was studied and
the total IgE antibody production after TNP-KLH
immunization. Moreover, we examined the effect of
continuous presence of systemic IFN-, on the
isotypes produced after immunization with
TNP-KLH adsorbed on alum. Besides the effects on
the primary response the influence of adjuvant on
the antigen specific IgE memory formation .was de-
termined.
Materials and Methods
Mice: Female BALB/c and C57BL/6 mice were bred
and maintained at the Department of Immunology of
the Erasmus University. All mice were aged 12-16
weeks at the start of the experiments. They were held
in light-cycled rooms and had access to acidified
water and pelleted food ad libitum. The microbio-
logical status of the mice fulfilled the standard of
’specific pathogen free V’, according to the criteria of
the Dutch Veterinary Inspection, as described in the
law on animal experiments. The experiments were
approved by the Animal Experiments Committee of
the Erasmus University.
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Immunization: KLH (Pierce, Rockford, IL, USA) was
tri-nitrophenylated to a level of 25 TNP residues
per 105Da of KLH (as determined spectro-
photometrically) by using tri-nitrobenzenesulfonic
acid (Eastman Kodak, Rochester, NY, USA).15 Mice
were injected with 0.2 ml containing either 10 l-tg or
100 btg TNP-KLH adsorbed on 2 mg alum. Alterna-
tively, either 10 l-tg or 100 l.tg TNP-KLH emulsified in
0.2 ml CFA was injected i.p., or 10 btg TNP-KLH in
saline was injected every 2 days until day 14, as
indicated in the results section.
Cytokine treatment: Mice immunized with 100 lttg
TNP-KLH adsorbed on alum were implanted i.p.
with 2 x 106 CHO/IFN-, cells encapsulated in alginate
on days 1, 14 and 28 as described previously for CV-
1/IL-4 cells.5q7 The CHO/IFN-, cells were a kind gift
of Dr N. Arai (DNAX Research Institute, Palo Alto,
CA, USA). Empty beads encapsulated in alginate
were used as control for the IFN-, treatment. No
immunological effects were observed as a result of
this treatment in all experiments.
Isotype spec’c ELISA: Total serum IgE, IgG1 and IgG2a
levels were measured by isotype specific ELISA
as described previously.5 Detection limits for the
IgE, IgG1 and IgG,. ELISA were 0.5 ng/ml, 0.2 ng/ml
and 0.3 ng/ml, respectively. TNP specific IgG1 and
IgE were determined as described previously, 15
with 0.2 ng/ml and 1 ng/ml as detection limit in the
ELISA, respectively. TNP-KLH specific IgG,. was
measured by direct ELISA. Plates were coated with
TNP-KLH (3 btg/ml), blocked with 1% BSA and
incubated with the appropriate dilutions of serum.
Subsequent steps with biotin conjugates GAM/IgG,a
(Southern Biotechnology, Birmingham, AL, USA),
SA-HRP (Jackson Immunoresearch, West Grove,
PA, USA) and the substrate 2,2’-azino-bis(3-
ethylbenz-thiazoline-6-sulfonic acid) (ATBS) (Sigma,
St. Louis, MO, USA). Purified TNP specific IgG,. was
used for the standard curve in this antigen
specific assay. The detection limit of this ELISA
was 0.4 ng/ml.
Con A stimulation of splenocytes: Spleen cells at
2 x 106/ml were cultured in RPMI 1640 medium sup-
plemented with 10% heat inactivated FCS, 2 mM
glutamine, 0.1 M pyruvate, 100 IU/ml penicillin,
50 l.tg/ml streptomycin, 50 t-tM 2-mercapto-ethanol in
six replicate wells of a 24-well fiat-bottom plate
(1 ml/well) with 10 l.tg/ml Concanavalin A (Sigma).
After 48 h culture supernatants were harvested and
stored at-70C before use.
Determination of cytokines: IL-4, IL-6, IL-10 an
IFN-q, were determined in ELISA as described previ-
ously.8-1 The detection limits of the ELISA were
0.2 ng/ml, 1.5 U/ml, 3 U/ml and 0.2 ng/ml, respec-
tively.
Adjuvants augment on-going immune responses
Statistical analysis: Differences between groups
were analyzed using Student’s t-test. Values of
p< 0.05 were considered significant.
Results and discussion
Mice were immunized i.p. with 100 btg TNP,5-KLH
either adsorbed on 2 mg alum or emulsified in CFA
(Table 1). On the days indicated serum was collected
and antigen specific IgG1 and IgG2a and total IgE
were determined in isotype specific ELISA. Serum
total IgE and TNP specific IgG1 and IgG2a peak levels
were not different whether TNP-KLH was given
adsorbed on alum or emulsified in CFA (Table 1).
Primary immunization of BALB/c mice with 100
TNP-KLH either adsorbed on alum or emulsified in
CFA provoked a response dominated by a 25-fold
increase in TNP specific IgG1 and resulting in a peak
level in the serum of 1.5 mg/ml. Even a proportional
higher increase was observed for TNP specific IgGia
upon immunization with 100 I.tg TNP-KLH, reaching
a maximum serum level of 54 l.tg/ml when adminis-
tered emulsified in CFA, and 78t.tg/ml when
adsorbed on alum (Table 1). With this does of
TNP-KLH employed the primary total IgE (Table 1)
and antigen specific IgE (data not shown) responses
were only marginal and did not differ between the
two adjuvants used. These results show that immune
responses induced by TNP-KLH immunization,
either adsorbed on alum or emulsified in CFA, do not
differ in the isotypes and amount of antibodies pro-
duced. Immunization of C57BL/6 mice with 100 l.tg
TNP-KLH adsorbed on alum resulted in an isotype
response pattern similar to that in BALB/c mice, and
also dominated by TNP specific IgG. The peak levels
of the isotypes produced, however, were consist-
ently 2-fold lower (Table 1).
It has been reported that immunization with
antigen emulsified in CFA induces T cells that pre-
dominantly produce IFN-,, and do not secrete IL-4.
Therefore, since IFN-, inhibits the IL-4 induced IgE
synthesis7,8 lower levels of IgE after immunizing
BALB/c mice with TNP-KLH in CFA would be ex-
pected, than when alum was used as adjuvant. Such
an inhibition was not observed (Table 1), suggesting
that CFA did not induce enough IFN-, to significantly
inhibit the TNP-KLH induced IgE production. There-
fore, we next studied the effect of continuous pres-
ence of IFN-, on total and antigen specific IgG1, IgG2
and IgE synthesis induced by immunization with
100 l.tg TNP-KLH adsorbed on alum. To ensure a
continuous systemic presence of IFN-7 CHO cells that
were stably transfected with the murine IFN-’ gene
and encapsulated in alginate were implanted in the
peritoneal cavity of BALB/c.mice 1 day before and 14
days after antigenic challenge. 15-17 Surprisingly, under
these conditions IFN-, augmented both the serum
total IgG and IgE levels, whereas it did not influence
the serum total IgGia levels (Table 2). However, IFN-
7 treatment markedly decreased the TNP specific IgG1
and IgE response, but did not influence the TNP
specific IgG2 response, at day 14 (data not shown).
In the literature, BALB/c mice were described as
IgE high-responder mice, whereas C57BL/6 mice
were described as IgE low-responder mice.22 Them-
fore, we next studied the effect of immunization with
TNP-KLH adsorbed on alum in the presence or
absence of exogenous IFN-7 on the IgGaa production
in C57BL/6 mice. In these mice, however, immuniza-
tion with TNP-KLH adsorbed on alum in the
presence of exogenous IFN-, also did not result in
increased serum total IgG, levels (data not shown).
Nevertheless, the lower IgE production found in
these mice upon TNP-KLH immunization (Table 1)
suggests a lower expression level of IL-4 and/or
higher level of IFN-,, than in BALB/c mice.
The encapsulated IFN-, producing cells secreted
enough biologically active IFN-, to enhance IgG2
synthesis, as was shown by implanting IFN-, produc-
ing cells in unimmunized naive BALB/c mice. The
serum total IgG2 levels significantly increased in
Table 1. Ig isotype distribution of IgG1, IgE and IgG2a antibodies after
immunization of BALB/c and C57BL/6 mice with TNP-KLH either on alum
or in CFA
Mice Adjuvant Isotype* Day 0 Day 14
BALB/c Alum IgE 1.6 +/- 0.3 3.0 +/- 0.5
anti-TNP IgG1 64 +/- 14 1544 +/- 59
anti-TNP IgGa, < 0.4 78 +/- 15
BALB/c CFA IgE 1.2 +/- 0.2 2.0 +/- 0.4
anti-TNP IgG 58 +/- 4 1485 +/- 68
anti-TNP IgG2a 2.0 +/- 0.1 54 +/- 9
C57BL/6 Alum IgE 0.1 +/- 0.01 1.2 +/- 0.4
anti-TNP IgG 3 +/- 0.1 929 +/- 130
anti-TNP IgGa, < 0.4 19 +/- 3
BALB/c or C57BL/6 mice were immunized i.p. either with 100 lg TNP-KLH
adsorbed on alum, or with 100 g TNP-KLH in CFA as indicated. *Total
IgE and TNP specific IgG and IgGa, serum levels were determined.
Results are presented as arithmetic mean +/- S.E.M. in g/ml (n 5).
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Table 2. Ig isotype distribution of IgG1, IgE and IgG2a antibodies after immunization of BALB/c
mice with TNP-KLH in the presence or absence of exogenous IFN-y
(A)
TNP-KLH/Alum
IgE (lg/ml) IgG (mg/ml) IgG2, (mg/ml)
No IFN-7 IFN-7 No IFN-7 IFN-7 No IFN-7 IFN-7
Day 0
Day 14
Day 51
(a)
No antigen
1.2 + 0.3 1.2 + 0.3 1.5 + 0.2 1.5 + 0.2 0.9 + 0.1 0.9 + 0.1
1.2 +/- 0.2 11.4 +/- 1.3 3.8 +/- 0.2 3.3 +/- 0.4 1.1 +/- 0.4 1.2 +/- 0.1
1.7 +/- 0.3 61.0 +/- 7.4* 3.5 +/- 0.1 11.7 +/- 1.2* 1.5 + 0.1 1.4 +/- 0.2
IgGs (mg/ml)
Alum Alum/IFN-7 IFN-7
Day 0 1.0 +/- 0.1 1.0 +/- 0.1 0.8 +/- 0.1
Day 14 0.7 +/- 0.1 1.9 +/- 0.3 1.4 + 0.2
Day 37 0.9 +/- 0.1 3.0 +/- 0.2** 1.7 + 0.3**
BALB/c mice were injected with either 100 Ig TNP-KLH adsorbed on alum (A), or alum alone
(B). 2 x 108 CHO/IFN-7 cells encapsulated in alginate, or empty beads encapsulated in alginate
were implanted i.p. on Day’1,14 and 28. Serum total IgE, IgG and IgGz, levels were determined.
Results are expressed as arithmetic mean +/- S.E.M. (n 5). Statistical evaluation using Students
t-test: *values were compared between control and IFN-7 treated mice (p < 0.05). **values were
compared relative to day 0 (p < 0.05).
these mice as a result of IFN-7 treatment (Table 2).
Moreover, when alum, without antigen, was given in
the presence of IFN-T, a further enhancement of IgG2a
synthesis was observed (Table 2). Alum alone did
not induce IgG2a production. These results suggest
that an adjuvant like alum augments ongoing im-
mune responses, in which the isotypes produced are
determined by the cytokines elicited upon antigen
stimulation.
Together these results suggest that upon immuni-
zation with TNP-KLH excessive IL-4 and less, or
strongly inhibited levels of IFN-T are induced. As a
result, no further increase in the serum total IgG2a
level was observed, when IFN-7 treatment was added
to TNP-KLH immunization adsorbed on alum (Table
2). The unexpected effects of the IFN-T treatment
with respect to the increased serum total IgG1 and IgE
cannot easily be explained. It is possible that the
amount of exogenously produced IFN-T was too low
to inhibit the IL-4 induced isotype switching to IgG1
and IgE. These two isotypes are coupled through the
23process 6f sequential isotype switching. Alterna-
tively, IFN-T levels could be high enough to support
polyclonal bystander activation by increasing the
MHC class II expression on macrophages and
dendritic cells, resulting in enhanced antigen presen-
tation.2.-26 It is known that IFN-7 decreases the IL-4
induced up-regulation of MHC class II molecules on
B cells. Therefore, it is possible that the observed
inhibition of the antigen specific IgG1 and IgE re-
sponse by IFN-T is the result of a down-regulation of
MHC class II molecules on the B cells, that are
essential for antigen specific T-B cell interactions.27
The possibility that the endogenous cytokine pro-
duction profile of spleen cells had changed as a
result of IFN-treatment was studied next. Therefore,
the cytokine production by Con A stimulated spleen
cells from control and IFN-T treated mice 1 day after
Table 3. Cytokine production profile of splenocytes day after the
last of ten IFN-7 administrations
Treatment IL-4 IL-6 IL-10 IFN-7
(ng/ml) (U/ml) (U/ml) (ng/ml)
Control 0.3 +/- 0.01 5.1 +/- 1.4 < 3 1.0 +/- 0.1
IFN-7 0.4 +/- 0.03 10.5 +/- 1.5* < 3 0.5 +/- 0.1"
Spleen cells (2 x 108/ml) pooled from either two control treated or
two IFN-7 treated BALB/c mice day after the last of ten control or
IFN-7 administrations were cultured with Con A (10 g/ml) for 48 h
in six replicate wells. The supernatants were harvested from these
wells and individually tested for cytokine production. The results
are represented as arithmetic mean +/- S.D. (n 6). *Statistical
evaluation using Student’s t-test p < 0.05.
the last control of ten control or IFN-T administrations
was determined. Similar amounts of IL-4 were de-
tected upon culturing spleen cells from control or
IFN-T treated mice, whereas no IL-10 production
could be detected (Table 3). The IL-6 production by
spleen cells from IFN-T treated mice was significantly
increased when compared to the IL-6 production by
spleen cells from control treated mice. However, the
IFN-7 production slightly decreased, in similar culture
conditions, as a result of IFN-T treatment (Table 3),
suggesting a negative feedback by IFN-T itself. The
increased ILo6 production in combination with un-
changed IL-4 production suggested an increase in the
number of activated macrophages and monocytes.
These results substantiate the authors’ opinion that
IFN-T, under the conditions used, merely acts on
these types of cells.
The preferential induction of IL-4 expression in
vivo by TNP-KLH immunization became clear by
injecting BALB/c mice repeatedly with 10tg
TNP-KLH in saline, that is every 2 days until day 14.
This immunization scheme resulted in 1.89 tg serum
total igE, 4-fold higher than the saline control (Fig.
1). Primary IgE production was determined because
of its total dependence on IL-4. 5,28,29 Immunization
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W
TNP-KLH in saline
me (days)
Saline
FIG 1. BALB/c mice were immunized with 10 lg TNP-KLH in saline (r3) or
saline alone (e) every 2 days until day 14, or immunized once with 10 lg
TNP-KLH adsorbed on alum at day 0 (B) Serum. total IgE levels were
determined on the days indicated. Results are expressed in g/ml as
arithmetic mean S.E.M. (n 5).
Antigen Adjuvant
with this dose of 10 t-tg TNP-KLH adsorbed on alum
resulted in a 20-fold increase of the serum total IgE
level at day 14 (Fig. 1). These results substantiate the
fact that TNP-KLH, itself, already induces IL-4 pro-
duction which is reflected by elevation of the total
serum IgE levels; whereas alum, used as adjuvant,
merely enhances the antigen induced antibody re-
sponse. Similar primary IgE responses were found
upon immunization with TNP-KLH either adsorbed
on alum, or in CFA (Table 1).
The effect of adjuvant on the memory formation
for IgE was then studied, because it is possible
that formation of memory B cells for IgE is more
dependent on the ratio of IL-4 and IFN-7 than the
primary IgE production. Therefore, BALB/c mice
were immunized i.p. either with 10 l.tg TNP-KLH
adsorbed on alum, or emulsified in CFA. This dose
of TNP-KLH was used because it elicits a significant
primary serum total IgE response (Fig. 1).
Three months later all mice were boosted with
TNP-KLH Alum
TNP-KLH CFA
Saline
Saline Alum
Saline CFA
I-] day 0
gl day 7
Total IgE (lg/ml)
20
TNP-KLH Alum
TNP-KLH CFA
Saline
Saline Alum
Saline CFA
0 1 32
TNP-spec. IgE (lg/ml)
FIG. 2. BALB/c mice were primed i.p. with 10 lg TNP-KLH either adsorbed on alum or emulsified in CFA as indicated. As a control alum or CFA was injected
in the absence of antigen. Three months later all mice were boosted with 10 lg TNP-KLH adsorbed on alum i.p. On day 0 and day 7 after booster total
and antigen specific serum IgE levels were determined in pooled sera of four mice. Results are expressed in lg/ml as arithmetic mean of three ELISA
determinations. [3, day 0; E3, day 7.
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10btg TNP-KLH adsorbed on alum. On day 7,
both total and antigen specific IgE serum levels
were determined in pooled sera of four mice (Fig. 2).
Under these conditions it did not make any
difference whether alum or CFA was used as
adjuvant during priming. Upon boosting with
10 btg TNP-KLH adsorbed on alum similar levels of
both antigen specific and total IgE were produced
at day 7 by mice primed either with TNP-KLH
adsorbed on alum or emulsified in CFA (Fig. 2).
It was therefore concluded that the memory forma-
tion for IgE is also not influenced by alum and CFA.
Collectively, the results show that when using
TNP-KLH as antigen, the resulting production of
IgG1, IgE and IgG2a is not dependent on the adjuvant
employed. CFA and alum rather act as enhancement
factors for ongoing antigen induced antibody re-
sponses, in which the carrier part of the antigen
determines the isotypes produced. Upon using KLH
as carrier, apparently an abundant IL-4 production is
generated by carrier specific Th-2 cells which is not
easily counteracted by IFN-T. Recently, it has been
described that IL-4 production is dependent on the
type of antigen and the duration of antigenic stimu-
lation.31 It is possible that repeated antigenic stimu-
lation of T cells, by immunization with TNP-KLH
every 2 days for 14 days, induces IL-4 production
resulting in IgE synthesis. When antigen is given
once, the use of adjuvant could result in an antigen
depot, resulting in repeated antigenic stimulation
and subsequent IL-4 production. This indicates that
IL-4 can be induced by antigen, independent of the
type of adjuvant, resulting in an antibody response
dominated by IgG1.
Fox13 has described that immunization with a pro-
tein antigen either given adsorbed on alum or emul-
sified in CFA induced similar T-cell proliferation and
cytokine production. Moreover, in this study it was
shown by limiting dilution analysis that comparable
frequencies of antigen specific T cells are induced by
the antigen, independent of the adjuvant used. These
data support our view that it is most likely the carrier
part of antigen that preferentially activates the devel-
opment of either Th-1 or Th-2 effector cells, after
which the adjuvant merely enhances the antibody
responses generated. The possibility that other types
of antigen in combination with either alum or CFA
will result in different isotype patterns cannot be
excluded. However, at the moment no such studies
are available with respect to the type of antibodies
tested in our study.
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